Download - Drug Information Center
![Page 1: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/1.jpg)
Drug Information Drug Information CenterCenter
Library without wallsLibrary without walls
![Page 2: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/2.jpg)
![Page 3: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/3.jpg)
![Page 4: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/4.jpg)
THAT MOMMENT CALL DIC
BUTFIRST U NEED TO KNOW• WHAT IS THE DIC?• WHY DIC?
![Page 5: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/5.jpg)
![Page 6: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/6.jpg)
HISTORY• The first drug information center
was established in the university of Kentucky in U.S.A.
• It is began operation in 1962
![Page 7: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/7.jpg)
LOCATION• DIC is centrally located in1. Major hospitals2. Major health care facility
• provide
better access to drug information
![Page 8: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/8.jpg)
Drug Information Specialists
• Are pharmacists who have received specialized training
• Generally in the form of 1year residency programs
![Page 9: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/9.jpg)
.
DIC provides
![Page 10: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/10.jpg)
Current informationuses the most recent up-to-date sources available .
.)
![Page 11: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/11.jpg)
valproic acid during pregnancy for migraine was category "D" (the potential benefit of the drug in pregnant women may be acceptable despite its potential risks)
![Page 12: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/12.jpg)
• use will be changed to "X" (the risk of use in pregnant women clearly outweighs any possible benefit of the drug).
• Valproate products will remain in pregnancy category D for treating epilepsy and manic episodes associated with bipolar disorder
• [posted 6-5-2013]
![Page 13: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/13.jpg)
Valproate Anti-Seizure Products Contraindicated for Pregnant Women for Prevention of Migraine Headaches
![Page 14: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/14.jpg)
Critically examinedShould meet the following criteria:
1. More than one source should be used when appropriate. 2. The extent of agreement between sources should be determined if sources don’t agree , good judgment should be used.
![Page 15: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/15.jpg)
Relevant data
Must be presented in a manner that applies directly to the circumstances under consideration )e.g., patient parameters, therapeutic objectives, alternative approaches
![Page 16: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/16.jpg)
Drug Information Specialists
• Specialists are skilled inI. Locating and evaluating drug
informationII. communicating with
pharmacists physicians and patients
![Page 17: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/17.jpg)
PHYSICAL FACILITIES• A secure space of approximately One or two rooms 32m2
![Page 18: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/18.jpg)
Allows for
• office work space• Storage of reference• Placement of equipment• Space for visitors
![Page 19: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/19.jpg)
THE PROCESS1. DETERMINING THE PRIMARY
QUESTIONS• Some questions require
immediate response other is not • some questions is patient specific
![Page 20: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/20.jpg)
2. DETERMINE THE NATURE OF THE PROBLEM AND OBTAINED DETAILS
Many patient don't under stand the difference between allergy and adverse reaction
![Page 21: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/21.jpg)
3. CHOOSING THE SOURCE OF INFORMATION
![Page 22: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/22.jpg)
![Page 23: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/23.jpg)
Primary sourcesPrimary sources are original materials on which research is basedo represent original thinkingo report on Discoverieso share new information
![Page 24: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/24.jpg)
Primary sourcesThey are usually the first formal appearance of results• neither interpreted • nor condensed • nor evaluated by other writers.
![Page 25: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/25.jpg)
examples of Primary sources
Scientific journal articles conferences and symposiaDissertations
![Page 26: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/26.jpg)
![Page 27: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/27.jpg)
Secondary sources•information reported in the
primary literature. Secondary sources are works on it in one or more steps
![Page 28: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/28.jpg)
Secondary sources•are those which review,
compare, contrast, repackage, reorganize, interpret, summarize, index or otherwise “add value” to the new
![Page 29: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/29.jpg)
examples of Secondary sources
• Reviewed articles• Biographical works• Monographs
![Page 30: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/30.jpg)
![Page 31: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/31.jpg)
Tertiary Sources• is a specific subject area, or
materials in which the information from secondary sources has been "digested"
• reformatted and condensed, to put it into a convenient, easy-to-read form.
![Page 32: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/32.jpg)
examples of Tertiary sources
• Textbooks• Handbooks
![Page 33: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/33.jpg)
![Page 34: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/34.jpg)
![Page 35: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/35.jpg)
4. DEVELOPING APPROPIATE SEARCH STRATEGY
![Page 36: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/36.jpg)
![Page 37: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/37.jpg)
![Page 38: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/38.jpg)
![Page 39: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/39.jpg)
![Page 40: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/40.jpg)
![Page 41: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/41.jpg)
![Page 42: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/42.jpg)
WHY DIC?
1-Lack of awareness of the principles of rational drug use among healthcare professionals.
![Page 43: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/43.jpg)
WHY DIC?2-There are more than 20,000
biomedical journals available and more than 6,000 articles published
everyday. It is not possible for a person to have access to all the information
![Page 44: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/44.jpg)
WHY DIC?
3-Lack of adequate drug information due to
limited availability lack of current literature poor documentationpoor funding available.
![Page 45: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/45.jpg)
WHY DIC?
4-Lack of unbiased drug information from the sources available
![Page 46: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/46.jpg)
![Page 47: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/47.jpg)
Objectives
1. Promote evidence based practice.
![Page 48: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/48.jpg)
![Page 49: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/49.jpg)
Objectives2 .Meet the patient’s needs while
providing pharmaceutical care
![Page 50: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/50.jpg)
Objectives3 .Improve the patient adherence
(To promote patient care through the rational use of medicines)
![Page 51: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/51.jpg)
Objectives4 .To provide accurate and unbiased
medicines information service to the healthcare professionals
4 .To provide accurate and unbiased medicines information service to the healthcare professionals
4 .To provide accurate and unbiased medicines information service to the healthcare professionals
![Page 52: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/52.jpg)
Objectives5 .To provide an organized database of
specialized information on medicines and therapeutics
![Page 53: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/53.jpg)
Services Offered1. Answer any drug related
questions Drug Interactions. Product Availability. Drug-Induced Adverse Effects Pharmacokinetics Pregnancy/Lactation IV Compatibility
![Page 54: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/54.jpg)
2.Drug information bulletins Transmission of information to the
members of health care team.
![Page 55: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/55.jpg)
3.educate pharmacy students to serve as an effective providers of medicines information.
![Page 56: Drug Information Center](https://reader035.vdocument.in/reader035/viewer/2022062503/5885a1e91a28abd2498b73b7/html5/thumbnails/56.jpg)